Trials / Completed
CompletedNCT04555187
Cardiovascular Risk Stratification in Covid-19
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,355 (actual)
- Sponsor
- Oregon Health and Science University · Academic / Other
- Sex
- All
- Age
- 18 Years – 89 Years
- Healthy volunteers
- Not accepted
Summary
This retrospective double-cohort study seeks to: 1. Describe the cardiovascular manifestations and electrophysiological (EP) substrate in COVID-19 infection and their association with clinical outcomes; and 2. Develop a method of cardiovascular risk stratification in COVID-19
Conditions
Timeline
- Start date
- 2020-06-08
- Primary completion
- 2021-12-01
- Completion
- 2021-12-01
- First posted
- 2020-09-18
- Last updated
- 2023-11-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04555187. Inclusion in this directory is not an endorsement.